
Amander Clark, Ph.D.
Bio
Amander Clark, Ph.D., is a stem cell scientist, geneticist and developmental biologist who studies reproductive cells of the ovaries and testes. Her research program combines stem cell biology, genetics and genomics to identify the genes and pathways that regulate human fertility and promote reproductive health. Clark hopes her research will create new options for people who face an infertility diagnosis and inform the development of novel contraceptive methods.
The Clark lab uses pluripotent stem cells to study the molecular and genetic events that regulate the production of ovarian follicular cells and germ cells, which create eggs or sperm. Clark and her team strive to characterize the key stages of healthy germ cell and ovarian follicle development to discover the genes, pathways and environmental factors that can disrupt this process, ultimately causing reproductive aging and infertility. According to the World Health Organization, infertility affects an estimated 186 million individuals worldwide and is common among cancer survivors whose eggs or sperm have been damaged by chemotherapy and radiation treatment and for women of advanced reproductive age experiencing ovarian failure.
In 2020, Clark and collaborators from Northwestern University, Rutgers University and MIT were awarded a grant from the Bill and Melinda Gates Foundation to establish the multi-disciplinary Ovarian Contraceptive Discovery Initiative. Her lab’s goal is to expand methods for reproductive choice by creating new approaches for contraceptive discovery screening through the use of stem cell differentiation. Contraceptive use has lifted millions of women and girls out of poverty, increased retention in school and ultimately enabled increased workforce participation. Developing new forms of accessible and low-cost contraceptives is essential to ensure choice, and that babies are born healthy and wanted.
Clark earned a doctorate degree in cell and developmental biology from the University of Melbourne and completed post-doctoral fellowships at Baylor College of Medicine and the University of California, San Francisco.
Publications
- TGFβ superfamily signaling regulates the state of human stem cell pluripotency and capacity to create well-structured telencephalic organoidsPublished in Stem Cell Reports on Thursday, September 29, 2022
- Human Primordial Germ Cells Are Specified from Lineage-Primed ProgenitorsPublished in Cell Reports on Tuesday, December 24, 2019
- TFAP2C regulates transcription in human naive pluripotency by opening enhancersPublished in Nature Cell Biology on Wednesday, April 25, 2018
- PRDM14 is expressed in germ cell tumors with constitutive overexpression altering human germline differentiation and proliferationPublished in Stem Cell Research on Monday, January 29, 2018
- Deriving Dorsal Spinal Sensory Interneurons from Human Pluripotent Stem CellsPublished in Stem Cell Reports on Thursday, January 11, 2018
- Nuclear Localization of Mitochondrial TCA Cycle Enzymes as a Critical Step in Mammalian Zygotic Genome ActivationPublished in Cell on Thursday, January 12, 2017
- Human Naive Pluripotent Stem Cells Model X Chromosome Dampening and X InactivationPublished in Cell Stem Cell on Thursday, December 15, 2016
- Human Embryonic Stem Cells Do Not Change Their X Inactivation Status during DifferentiationPublished in Cell Reports on Thursday, December 15, 2016
- Naive Human Pluripotent Cells Feature a Methylation Landscape Devoid of Blastocyst or Germline MemoryPublished in Cell Stem Cell on Thursday, February 4, 2016
- DNA Demethylation Dynamics in the Human Prenatal GermlinePublished in Cell on Thursday, May 21, 2015
- MORC1 represses transposable elements in the mouse male germlinePublished in Nature Communications on Friday, December 12, 2014
- Stage-Specific Roles for Tet1 and Tet2 in DNA Demethylation in Primordial Germ CellsPublished in Cell Stem Cell on Thursday, February 14, 2013
- The ontogeny of cKIT+ human primordial germ cells proves to be a resource for human germ line reprogramming, imprint erasure and in vitro differentiationPublished in Nature Cell Biology on Sunday, December 16, 2012
- From skin biopsy to neurons through a pluripotent intermediate under good manufacturing practice protocolsPublished in Stem Cells Translational Medicine on Wednesday, December 7, 2011
- Derivation of new human embryonic stem cell lines reveals rapid epigenetic progression in vitro that can be prevented by chemical modification of chromatinPublished in Human Molecular Genetics on Friday, November 4, 2011
- Female human iPSCs retain an inactive X chromosomePublished in Cell Stem Cell on Friday, September 3, 2010
- Relationship between nucleosome positioning and DNA methylationPublished in Nature on Sunday, May 30, 2010
- Induced Pluripotent Stem Cells and Embryonic Stem Cells Are Distinguished by Gene Expression SignaturesPublished in Cell Stem Cell on Thursday, July 2, 2009
- Directed Differentiation of Human‐Induced Pluripotent Stem Cells Generates Active Motor NeuronsPublished in Stem Cells on Monday, February 23, 2009
- Generation of human induced pluripotent stem cells from dermal fibroblastsPublished in PNAS on Tuesday, February 26, 2008
- UHRF1 Plays a Role in Maintaining DNA Methylation in Mammalian CellsPublished in Science on Thursday, August 2, 2007
Honors & Affiliations
Honors
- Young Investigator Award, Concern Foundation, 2015
- Young Investigator Award, Lance Armstrong Foundation, 2007
- Career Development Award, STOP Cancer Foundation, 2007
- Young Investigator Award, International Society for Stem Cell Research, 2003
Affiliations
- President-Elect, International Society for Stem Cell Research
- Elected Vice President, International Society for Stem Cell Research
- International Society for Stem Cell Research
- American Society for Reproductive Medicine
- Society for the Study of Reproduction
- The Hinxton Group
- UCLA Jonsson Comprehensive Cancer Center Cancer and Stem Cell Biology Program
- UCLA Molecular Biology Institute
Funding
Clark’s work is funded by the National Institute for Child Health and Human Development, California Institute for Regenerative Medicine, Bill and Melinda Gates Foundation, STOP Cancer, the Lance Armstrong Foundation, Templeton Foundation and the Iris Cantor-UCLA Women’s Health Center.